Drugs / OraTest
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00537199 | Nov 2006 → Dec 2008 | oropharynx cancer | M.D. Anderson Cancer Center | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OraTest | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00537199 ↗ |
| Modality | Diagnostic / imaging agent | “This new test uses a blue dye which may stain any potential cancer blue so it may make it easier for the doctor to detect any abnormal lesions in your mouth.” NCT00537199 ↗ |
| Route | Other | “Then you will rinse your mouth with about 2 teaspoons of OraTest® for 20 seconds and spit it out.” NCT00537199 ↗ |